Collegium Pharmaceutical Inc (COLL)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	48,155	-25,002	71,517	26,752	-22,722
Revenue	US$ in thousands	459,924	400,720	255,854	281,134	295,792
Net profit margin		10.47%	-6.24%	27.95%	9.52%	-7.68%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $48,155K ÷ $459,924K
= 10.47%

Collegium Pharmaceutical Inc's net profit margin has varied significantly over the past five years. In 2023, the net profit margin improved to 8.50%, indicating that the company was able to generate 8.50 cents of profit for every dollar of revenue. This is a positive trend compared to the previous years. In 2022, the company had a negative net profit margin of -5.39%, indicating that it incurred a loss of 5.39 cents for every dollar of revenue. However, in 2021, the net profit margin was notably high at 25.83%, suggesting efficient cost management and strong revenue generation. In 2020, the net profit margin stood at 8.63%, showing a moderate level of profitability, while in 2019, the company experienced a negative net profit margin of -7.66%.

Overall, Collegium Pharmaceutical Inc's net profit margin has been volatile, with fluctuations between positive and negative margins. It is essential for the company to continue monitoring and improving its cost structure and revenue generation to ensure consistent profitability in the future.